Biocurity Pharmaceuticals C/A Crowdfunding $10K to $600K in Series 2 CF Convertible Preferred Stock

schemaVersion:

FORM C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
FORM C/A		OMB Number: ####-#### Estimated average burden hours per response: ##.#

Form C: Filer Information

Filer CIK:	0001639681
Filer CCC:	XXXXXXXX
File Number:	020-26711
Is this a LIVE or TEST Filing?	LIVE TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?
Would you like a Return Copy?

Submission Contact Information

Name:
Phone Number:
Contact E-Mail Address:
Notify via Filing Website only?

Form C: Issuer Information

Issuer Information

Name of Issuer:	BIOCURITY PHARMACEUTICALS INC.
Check box if Amendment is material and investors will have five business days to reconfirm
Describe the Nature of the Amendment:	Issuer is extending their campaign for 60 days.

Legal Status of Issuer:

Form:	Corporation
Jurisdiction of Incorporation/Organization:	DELAWARE
Date of Incorporation/Organization:	10-16-2016

Physical Address of Issuer:

Address 1:	110 FRONT STREET, SUITE 300
Address 2:	SUITE 300
City:	JUPITER
State/Country:	FLORIDA
Mailing Zip/Postal Code:	33477
Website of Issuer:	http://www.biocurity.com/

Intermediary through which the Offering will be Conducted:

CIK:	0001665160
Company Name:	StartEngine Capital, LLC
Commission File Number:	007-00007

Form C: Offering Information

Offering Information

Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering:	7.0 percent
Any other financial interest in the issuer held by the intermediary, or any arrangement for the intermediary to acquire such an interest:	Two percent (2%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Type of Security Offered:	Other
Specify:	Series 2 CF Convertible Preferred Stock

Target Number of Securities to be Offered:	2352
Price:	4.25000
Price (or Method for Determining Price):	N/A
Target Offering Amount:	9996.00
Maximum Offering Amount (if different from Target Offering Amount):	599998.00

Oversubscriptions Accepted:	Yes No
If yes, disclose how oversubscriptions will be allocated:	Other
Provide a description:	At issuer's discretion, with priority given to StartEngine Owners
Deadline to reach the Target Offering Amount:	12-28-2020

NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned.

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:	1.00
Total Assets Most Recent Fiscal Year-end:	222611.00
Total Assets Prior Fiscal Year-end:	342484.00
Cash and Cash Equivalents Most Recent Fiscal Year-end:	62215.00
Cash and Cash Equivalents Prior Fiscal Year-end:	167281.00
Accounts Receivable Most Recent Fiscal Year-end:	0.00
Accounts Receivable Prior Fiscal Year-end:	0.00
Short-term Debt Most Recent Fiscal Year-end:	1524330.00
Short-term Debt Prior Fiscal Year-end:	780203.00
Long-term Debt Most Recent Fiscal Year-end:	0.00
Long-term Debt Prior Fiscal Year-end:	0.00
Revenue/Sales Most Recent Fiscal Year-end:	0.00
Revenue/Sales Prior Fiscal Year-end:	0.00
Cost of Goods Sold Most Recent Fiscal Year-end:	0.00
Cost of Goods Sold Prior Fiscal Year-end:	0.00
Taxes Paid Most Recent Fiscal Year-end:	0.00
Taxes Paid Prior Fiscal Year-end:	0.00
Net Income Most Recent Fiscal Year-end:	-2191060.00
Net Income Prior Fiscal Year-end:	-1570893.00

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: ALABAMA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: ALASKA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: ARIZONA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: ARKANSAS

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: CALIFORNIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: COLORADO

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: CONNECTICUT

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: DELAWARE

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: DISTRICT OF COLUMBIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: FLORIDA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: GEORGIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: HAWAII

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: IDAHO

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: ILLINOIS

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: INDIANA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: IOWA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: KANSAS

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: KENTUCKY

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: LOUISIANA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MAINE

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MARYLAND

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MASSACHUSETTS

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MICHIGAN

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MINNESOTA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MISSISSIPPI

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MISSOURI

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: MONTANA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEBRASKA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEVADA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEW HAMPSHIRE

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEW JERSEY

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEW MEXICO

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NEW YORK

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NORTH CAROLINA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: NORTH DAKOTA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: OHIO

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: OKLAHOMA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: OREGON

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: PENNSYLVANIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: PUERTO RICO

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: RHODE ISLAND

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: SOUTH CAROLINA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: SOUTH DAKOTA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: TENNESSEE

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: TEXAS

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: UTAH

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: VERMONT

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: VIRGINIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: WASHINGTON

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: WEST VIRGINIA

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: WISCONSIN

Using the list below, select the jurisdictions in which the issuer intends to offer the securities: WYOMING

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:	BIOCURITY PHARMACEUTICALS INC.
Signature:	MerchantCass Advisors, LLC Nancy Cass
Title:	Principal Executive Officer

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	MerchantCass Advisors, LLC Nancy Cass
Title:	Principal Executive Officer
Date:	10-23-2020

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Dr. Cheryl Baker, PhD
Title:	Scientific Founder and Director, Principal Financial Officer and Principal Accounting Officer
Date:	10-23-2020